The 2010 introduction of PCV10 for infants in Finland led to an estimated 15% reduction among unvaccinated children in purchases of antimicrobials recommended for acute otitis media (AOM), the most common reason for antimicrobial use in many countries. The indirect effects of PCV10 introduction contribute to health care savings and may also help to combat antimicrobial resistance.
Full Citation:
Palmu AA, Rinta-Kokko H, Nohynek H et al.. 2020. Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland. The Pediatric Infectious Disease Journal. 39(9).
Title of Article: Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland
Author(s): Palmu AA, Rinta-Kokko H, Nohynek H et al.
Publication Year: 2020
Publication Name: The Pediatric Infectious Disease Journal
Publication Volume: 39(9)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/32412982/
DOI (Digital Object Identifier): 10.1097/INF.0000000000002696
Topics: Antibiotic Resistance | Global Issues
Disease Vaccines: Pneumococcal disease/PCV/PPSV
Countries: Finland
WHO Regions: Europe